China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 142.7% in April

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 63,600 shares, a growth of 142.7% from the March 31st total of 26,200 shares. Approximately 11.6% of the company’s shares are sold short. Based on an average daily volume of 1,220,000 shares, the days-to-cover ratio is currently 0.1 days.

China SXT Pharmaceuticals Stock Performance

Shares of SXTC stock traded up $0.02 during mid-day trading on Friday, reaching $1.05. 203,439 shares of the stock traded hands, compared to its average volume of 2,344,629. The stock’s fifty day simple moving average is $1.68 and its two-hundred day simple moving average is $2.01. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.41 and a current ratio of 1.47. China SXT Pharmaceuticals has a 1-year low of $0.94 and a 1-year high of $9.38.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.